Bob Wesdorp

Bob Wesdorp

Bob Wesdorp is content marketing manager at TRACER. He writes and edits blogs and social media content. He has extensive knowledge of the concept of Phase 0 research (also known as exploratory or early-Phase 1) and antibodies in drug development. He understands better than anyone that scientists have a narrow framework in which they know a vast amount, but that doing clinical research requires looking outside one's own areas of expertise. He therefore writes content for every level of knowledge, inspiring and educating the reader with possibilities they can apply in their clinical research.

Blog

Learning and development at TRACER

Bob Wesdorp
Blog

Types of antibodies

Bob Wesdorp
Blog

Antibody fragments

Bob Wesdorp
Blog

Nanobody® vs antibody

Bob Wesdorp
Blog

Guide on monoclonal antibody naming

Bob Wesdorp
Blog

5 differences between Phase 1 0 in drug development

Bob Wesdorp
Blog

How long is Phase 0 in clinical trials?

Bob Wesdorp